Listed

Avalyn Pharma Inc.

AVLNNasdaqCIK 1540171HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$31.3m, Q2 FY2026
Net income−$28.9m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m15.3Research and development, period not labelled, three months to 2025-03-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure17.9Research and development, period not labelled, three months to 2025-06-30$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure22.9Research and development, Q1 FY2026, three months to 2026-03-31$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure24.7Research and development, Q2 FY2026, three months to 2026-06-30$24.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Operating income$m(18.7)Operating income, period not labelled, three months to 2025-03-31−$18.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(21.8)Operating income, period not labelled, three months to 2025-06-30−$21.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(27.9)Operating income, Q1 FY2026, three months to 2026-03-31−$27.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(31.3)Operating income, Q2 FY2026, three months to 2026-06-30−$31.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Interest expense$m0.0Interest expense, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure0.0Interest expense, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure0.1Interest expense, Q1 FY2026, three months to 2026-03-31$98.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure0.3Interest expense, Q2 FY2026, three months to 2026-06-30$272.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure0.0Income tax, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-345820. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-345820. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(17.5)Net income, period not labelled, three months to 2025-03-31−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(20.2)Net income, period not labelled, three months to 2025-06-30−$20.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(26.9)Net income, Q1 FY2026, three months to 2026-03-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(28.9)Net income, Q2 FY2026, three months to 2026-06-30−$28.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Diluted EPS$ per share(63.24)Diluted EPS, period not labelled, three months to 2025-03-31−$63.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(17.63)Diluted EPS, period not labelled, three months to 2025-06-30−$17.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(21.83)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$21.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(0.98)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Basic EPS$ per share(63.24)Basic EPS, period not labelled, three months to 2025-03-31−$63.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(17.63)Basic EPS, period not labelled, three months to 2025-06-30−$17.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(21.83)Basic EPS, Q1 FY2026, three months to 2026-03-31−$21.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(0.98)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure

Balance sheet

Cash and equivalents$264.2m, Q2 FY2026
Long-term debt$14.8m, Q2 FY2026
Shareholders' equity$398.3m, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30period not labelled2025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reported52.3Cash and equivalents, period not labelled, at 2025-12-31$52.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure92.3Cash and equivalents, Q1 FY2026, at 2026-03-31$92.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure264Cash and equivalents, Q2 FY2026, at 2026-06-30$264.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Current assets$mnot reportednot reportednot reported144Current assets, period not labelled, at 2025-12-31$143.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure130Current assets, Q1 FY2026, at 2026-03-31$130.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure358Current assets, Q2 FY2026, at 2026-06-30$358.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Total assets$mnot reportednot reportednot reported149Total assets, period not labelled, at 2025-12-31$148.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure136Total assets, Q1 FY2026, at 2026-03-31$135.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure425Total assets, Q2 FY2026, at 2026-06-30$425.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Current liabilities$mnot reportednot reportednot reported14.1Current liabilities, period not labelled, at 2025-12-31$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure11.8Current liabilities, Q1 FY2026, at 2026-03-31$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure10.8Current liabilities, Q2 FY2026, at 2026-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Total liabilities$mnot reportednot reportednot reported15.3Total liabilities, period not labelled, at 2025-12-31$15.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure27.7Total liabilities, Q1 FY2026, at 2026-03-31$27.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure27.1Total liabilities, Q2 FY2026, at 2026-06-30$27.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Long-term debt$mnot reportednot reportednot reported0.0Long-term debt, period not labelled, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure14.8Long-term debt, Q1 FY2026, at 2026-03-31$14.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure14.8Long-term debt, Q2 FY2026, at 2026-06-30$14.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure
Shareholders' equity$m(175)Shareholders' equity, period not labelled, at 2024-12-31−$174.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(192)Shareholders' equity, period not labelled, at 2025-03-31−$191.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(194)Shareholders' equity, period not labelled, at 2025-06-30−$194.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(239)Shareholders' equity, period not labelled, at 2025-12-31−$238.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure(264)Shareholders' equity, Q1 FY2026, at 2026-03-31−$264.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure398Shareholders' equity, Q2 FY2026, at 2026-06-30$398.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure

Cash flow

Operating cash flow−$26.1m, Q2 FY2026
Capital expenditure$269.0k, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(19.3)Operating cash flow, period not labelled, three months to 2025-03-31−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(20.7)Operating cash flow, period not labelled, three months to 2025-06-30−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345820. Derived: 6-month figure less the 3-month figure.Report this figure(29.9)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$29.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure(26.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345820. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2025-03-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345820. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$318.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure0.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$269.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001193125-26-345820. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)29.65m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.3Diluted shares (weighted), period not labelled, three months to 2025-03-31276,792 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure1.1Diluted shares (weighted), period not labelled, three months to 2025-06-301,145,309 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure1.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,230,698 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-03, accession 0001193125-26-254623.Report this figure29.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3029,650,660 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure

Shares outstanding: 44.33mShares outstanding, period not labelled, at 2026-08-3144,333,095 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345820.Report this figure at Aug 31, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.